Dr Bette J Bischoff Glidewell, MD | |
3401 W Gore Blvd, Lawton, OK 73505-6332 | |
(580) 510-7037 | |
(580) 510-7038 |
Full Name | Dr Bette J Bischoff Glidewell |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 3401 W Gore Blvd, Lawton, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134309933 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 04-33670 (Kansas) | Secondary |
208M00000X | Hospitalist | 28027 (Oklahoma) | Primary |
207R00000X | Internal Medicine | 28027 (Oklahoma) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Bette J Bischoff Glidewell, MD 6600 S Yale Ave, Ste 1200, Tulsa, OK 74136-3361 Ph: (918) 488-6687 | Dr Bette J Bischoff Glidewell, MD 3401 W Gore Blvd, Lawton, OK 73505-6332 Ph: (580) 510-7037 |
News Archive
This Altarum Institute Policy Roundtable will consider the role of the Special Supplemental Nutrition Program for Women, Infants, and Children ("WIC") in childhood obesity prevention, how the program is already addressing the childhood obesity epidemic, and – with the reauthorization of the Child Nutrition Act imminent – what policy changes may be needed to ensure WIC can be successful in addressing childhood obesity.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
Genix Healthcare Ltd celebrated the 10th anniversary of its first dental practice with a special visit by Alec Shelbrooke, the Conservative MP for Elmet and Rothwell.
Researchers at the National Institutes of Health have discovered a second gene that causes melorheostosis, a rare group of conditions involving an often painful and disfiguring overgrowth of bone tissue.
A number of herbs and dietary supplements (HDS) can cause potentially harmful drug interactions, particularly among people receiving medication for problems with their central nervous or cardiovascular systems.
› Verified 5 days ago
Alexander F Degazon, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5602 Sw Lee Blvd, Southwest Medical Center, Lawton, OK 73505 Phone: 580-531-4700 | |
Pamela J Barry Duguid, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3201 W Gore Blvd, Suite 202, Lawton, OK 73505 Phone: 580-355-6731 Fax: 580-250-5806 |